2019 House and Senate language on Amyloidosis
August 24, 2018 Last night the Senate passed the fiscal year 2019 Labor HHS bill. This is the first time the bill has passed the Senate floor in a decade. This gives more emphasis to language included in the Senate and House reports on Amyloidosis and the hope for completing a House Senate conference and […]
FDA COULD MAKE A HISTORIC DECISION FOR AMYLOIDOSIS PATIENTS
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision